Roche Holding's cancer drug Avastin has been rejected by Britain's healthcare cost agency as a first-line treatment for advanced breast cancer, the latest in a series of setbacks for this medicine.
The National Institute for Health and Cli
A new batch of counterfeit Avastin discovered in the United States was shipped from Britain after being purchased from a Turkish wholesaler by a British-based business, officials said on Wednesday.
The pattern of shipments from the Middle
The US Food and Drug Administration (FDA) has alerted health care professionals that repackaged intravitreal injections of Avastin (bevacizumab) have caused a cluster of serious eye infections in the Miami, Florida.
The Florida Department
US health advisers unanimously rejected use of the drug Avastin for breast cancer, dealing a blow to its manufacturer and patients who insisted that the medicine saved their lives.
Advisers to the US Food and Drug Administration agreed tha
Avastin, a cancer drug made by Roche Holding, was about as effective as the company's far more expensive eye drug, Lucentis, at preventing vision loss in people with age-related macular degeneration, the New York Times reported.
Women with advanced breast cancer who were treated with Roche's Avastin were more likely to develop heart failure than other women, according to an analysis that raised more concerns about the already troubled drug.
A team led by Dr To
Avastin, the world's best-selling cancer medicine, should no longer be approved for breast cancer, US officials said on Thursday in an unusual move that could shave $1 billion from manufacturer Roche's annual sales.
European authorities, m
US regulators have extended by three months a review of Roche Holding's blockbuster drug Avastin in breast cancer, the company said.
The Food and Drug Administration has made no decision on whether to revoke Avastin's approval for
Long-term use of Swiss drugmaker Roche Holding’s Avastin, in combination with chemotherapy, helped women with advanced ovarian cancer live longer without their cancer getting worse, according to results from a new study.
The trial, funded
Women with advanced ovarian cancer who are treated with Roche's Avastin and chemotherapy and then continue to take Avastin live longer without their disease worsening than if they only have chemotherapy, the Swiss drugmaker said.